Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epirubicin, Estramustine, and Celecoxib in HRPC
NCT00218205Phase 2Unknown
- Sponsor
- United States Department of Veterans Affairs
- Start
- Jul 2002
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in castration-resistant prostate cancer (CRPC), sponsored by United States Department of Veterans Affairs. Status: unknown.
02
Drugs
celecoxib
03
Conditions
castration-resistant prostate cancer (CRPC)
Beyond the preview
Go deeper on NCT00218205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218205.